Dr. Reynolds Delgado III

El Dr. Reynolds M. Delgado, III es cardiólogo especializado en insuficiencia cardíaca y trasplante cardíaco en el Baylor St. Luke's Medical Center/The Texas Heart Institute. Ha sido investigador de ciencias básicas en insuficiencia cardíaca en el Texas Heart Institute, el Baylor College of Medicine y la University of Texas Houston Medical School desde 1997, y ha ocupado el cargo de director médico de dispositivos de soporte mecánico en insuficiencia cardíaca en el Texas Heart Institute desde 2003. Sus nombramientos académicos incluyen profesor clínico adjunto de medicina en el Baylor College of Medicine y el UT Health Science Center, Houston. Participa en numerosos consejos asesores, entre ellos Thoratec Corporation, Medtronic Corporation y Boston Scientific Corporation, y ha formado parte del Comité de Educación Médica del Texas Heart Institute desde 2004. También colabora desde hace mucho tiempo en la investigación con el Laboratorio de Fisiología de Vuelos Espaciales Humanos del Centro Espacial Johnson de la NASA.

Mostrar biografía completa

El Dr. Delgado obtuvo una Licenciatura en Artes de la Universidad de Texas en Austin en 1987 y un título de médico de la Facultad de Medicina de la Universidad de Texas Southwestern en Dallas en 1991. Completó una residencia en medicina interna en la Facultad de Medicina de la Universidad de Texas Southwestern y una beca de investigación en cardiología en el Centro de Ciencias de la Salud de la Universidad de Texas en Houston. En ese programa de becas se incluyó una beca de 15 meses en insuficiencia cardíaca y trasplante cardíaco clínico en The Texas Heart Institute.

Creó el programa de la clínica de insuficiencia cardíaca en el Centro Médico Baylor St. Luke y forma parte de la Junta de Revisión Médica de Trasplantes allí. Como resultado de su amplia experiencia en el campo de la insuficiencia cardíaca y los trasplantes, fue uno de los cuatro médicos de todo el mundo a los que se pidió que desarrollaran las Directrices para la atención de los receptores de trasplantes de corazón de la Sociedad Internacional de Trasplantes de Corazón y Pulmón. También es autor de “Apoyo circulatorio mecánico en pacientes con insuficiencia cardíaca”, incluido en el libro de texto definitivo. Insuficiencia de salud: un compañero de la enfermedad cardíaca de Braunwald.

El Dr. Delgado es autor o coautor de numerosos artículos para las principales revistas científicas, incluido el New England Journal of Medicine, Revista de trasplante de corazón y pulmón, Insuficiencia cardíaca congestiva y Circulación, la principal revista de la American Heart Association. Actualmente es o ha sido miembro de los consejos editoriales de Revista del Instituto del Corazón de Texas, Circulación, y Revista de trasplante de corazón y pulmón. Da conferencias extensamente, con presentaciones en México, Canadá, Grecia, Francia, Serbia, Eslovenia y Argentina, entre otros lugares.

Ver Publicaciones

Posiciones del Instituto del Corazón de Texas

Proyectos actuales

Intereses

  • Cardiología
  • Insuficiencia Cardíaca

Educación

  • De licenciatura:

    La Universidad de Texas (Biología)

  • Escuela de Medicina:

    La Facultad de Medicina de la Universidad de Texas Southwestern

  • Residencia:

    La Universidad de Texas Southwestern - Parkland Health & Hospital System

  • Becas:

    El Centro de Ciencias de la Salud de la Universidad de Texas - Houston
    The Texas Heart Institute, Insuficiencia cardíaca y trasplante cardíaco

Afiliaciones académicas y clínicas

  • Baylor College of Medicine
  • Centro Médico Baylor St. Luke

Certificaciones

  • Junta Americana de Medicina Interna
  • Insuficiencia cardíaca avanzada/cardiología de trasplantes

Honores, premios y membresías

Publicaciones

4862227 CONSEJO3BD5 1 alternativas-a-la-experimentación-con-animales 10 datos desc Delgado 1884 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22KIK8DC32%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chou%20et%20al.%22%2C%22parsedDate%22%3A%222021-09-01%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChou%2C%20B.%20P.%2C%20Critsinelis%2C%20A.%2C%20Lamba%2C%20H.%20K.%20et%20al.%20%282021%29.%20Continuous-flow%20left%20ventricular%20assist%20device%20support%20in%20patients%20with%20ischemic%20versus%20nonischemic%20cardiomyopathy.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B48%26lt%3B%5C%2Fi%26gt%3B%2C%20e207241.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-20-7241%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-20-7241%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Continuous-flow%20left%20ventricular%20assist%20device%20support%20in%20patients%20with%20ischemic%20versus%20nonischemic%20cardiomyopathy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brendan%20P.%22%2C%22lastName%22%3A%22Chou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andre%22%2C%22lastName%22%3A%22Critsinelis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harveen%20K.%22%2C%22lastName%22%3A%22Lamba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%22%2C%22lastName%22%3A%22Long%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20B.%22%2C%22lastName%22%3A%22Civitello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%20M.%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhasis%22%2C%22lastName%22%3A%22Chatterjee%22%7D%5D%2C%22abstractNote%22%3A%22To%20determine%20whether%20the%20cause%20of%20cardiomyopathy%20affects%20outcomes%20in%20patients%20who%20undergo%20continuous-flow%20left%20ventricular%20assist%20device%20support%2C%20we%20compared%20postimplant%20adverse%20events%20and%20survival%20between%20patients%20with%20ischemic%20and%20nonischemic%20cardiomyopathy.%20The%20inclusion%20criteria%20for%20the%20ischemic%20group%20were%20a%20history%20of%20myocardial%20infarction%20or%20revascularization%20%28coronary%20artery%20bypass%20grafting%20or%20percutaneous%20coronary%20intervention%29%2C%20%5Cu226575%25%20stenosis%20of%20the%20left%20main%20or%20proximal%20left%20anterior%20descending%20coronary%20artery%2C%20or%20%5Cu226575%25%20stenosis%20of%20%5Cu22652%20epicardial%20vessels.%20From%20November%202003%20through%20March%202016%2C%20526%20patients%20underwent%20device%20support%3A%20256%20%2848.7%25%29%20in%20the%20ischemic%20group%20and%20270%20%2851.3%25%29%20in%20the%20nonischemic%20group.%20The%20ischemic%20group%20was%20older%20%2860.0%20vs%2050.0%20yr%29%2C%20included%20more%20men%20than%20women%20%2884.0%25%20vs%2072.6%25%29%2C%20and%20had%20more%20comorbidities.%20More%20patients%20in%20the%20nonischemic%20group%20were%20able%20to%20have%20their%20devices%20explanted%20after%20left%20ventricular%20recovery%20%285.9%25%20vs%202.0%25%3B%20P%3D0.02%29.%20More%20patients%20in%20the%20ischemic%20group%20had%20gastrointestinal%20bleeding%20%2831.2%25%20vs%2022.6%25%3B%20P%3D0.03%29%2C%20particularly%20from%20arteriovenous%20malformations%20%2820.7%25%20vs%2011.9%25%3B%20P%3D0.006%29%20and%20ulcers%20%2816.4%25%20vs%209.3%25%3B%20P%3D0.01%29.%20Kaplan-Meier%20analysis%20revealed%20no%20difference%20in%20overall%20survival%20between%20groups%20%28P%3D0.24%29.%20Older%20age%2C%20previous%20sternotomy%2C%20higher%20total%20bilirubin%20level%2C%20and%20concomitant%20procedures%20during%20device%20implantation%20independently%20predicted%20death%20%28P%20%5Cu22640.03%29%2C%20whereas%20cause%20of%20heart%20failure%20did%20not%20%28P%3D0.08%29.%20Despite%20the%20similarity%20in%20overall%20survival%20between%20groups%2C%20ischemic%20cardiomyopathy%20was%20associated%20with%20more%20frequent%20gastrointestinal%20bleeding.%20This%20information%20may%20help%20guide%20the%20care%20of%20patients%20with%20ischemic%20cardiomyopathy%20who%20receive%20continuous-flow%20left%20ventricular%20assist%20device%20support.%22%2C%22date%22%3A%22Sept%2001%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-20-7241%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%229FBUJBMU%22%2C%22TIPQ3BD5%22%2C%22VCK5HVUS%22%5D%2C%22dateModified%22%3A%222022-01-25T15%3A04%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22TMA8G96M%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parikh%20et%20al.%22%2C%22parsedDate%22%3A%222020-11%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BParikh%2C%20V.%20Y.%2C%20Parikh%2C%20U.%20M.%2C%20Moctezuma-Ramirez%2C%20A.%20et%20al.%20%282020%29.%20Factor%20Xa%20inhibitors%20in%20patients%20with%20continuous-flow%20left%20ventricular%20assist%20devices.%20%26lt%3Bi%26gt%3BGen%20Thorac%20Cardiovasc%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B68%26lt%3B%5C%2Fi%26gt%3B%2C%201278%26%23x2013%3B1284.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11748-020-01371-w%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11748-020-01371-w%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Factor%20Xa%20inhibitors%20in%20patients%20with%20continuous-flow%20left%20ventricular%20assist%20devices%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vishal%20Y.%22%2C%22lastName%22%3A%22Parikh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Umang%20M.%22%2C%22lastName%22%3A%22Parikh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angel%22%2C%22lastName%22%3A%22Moctezuma-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harveen%20K.%22%2C%22lastName%22%3A%22Lamba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%20K.%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Savitri%22%2C%22lastName%22%3A%22Fedson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%20P.%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%20M.%22%2C%22lastName%22%3A%22Delgado%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20Warfarin%20is%20standard%20anticoagulation%20therapy%20for%20patients%20with%20a%20continuous-flow%20left%20ventricular%20assist%20device%20%28CF-LVAD%29.%20However%2C%20warfarin%20requires%20regular%20monitoring%20and%20dosage%20adjustments%20and%20fails%20for%20many%20patients%2C%20causing%20thromboembolic%20and%20bleeding%20events.%20Factor%20Xa%20inhibitors%20have%20been%20shown%20to%20be%20noninferior%20to%20warfarin%20in%20preventing%20strokes%20and%20are%20associated%20with%20less%20intracranial%20hemorrhage%20in%20patients%20with%20atrial%20fibrillation.%20We%20evaluated%20treatment%20safety%20and%20effectiveness%20in%20CF-LVAD%20patients%20who%20switched%20from%20warfarin%20to%20a%20factor%20Xa%20inhibitor%20%28apixaban%20or%20rivaroxaban%29%20after%20warfarin%20failure.%5CnMETHODS%3A%20This%20was%20a%20retrospective%2C%20single-center%20study%20of%20patients%20treated%20between%202008%20and%202018.%20We%20assessed%20the%20occurrence%20of%20stroke%2C%20non-central%20nervous%20system%20%28CNS%29%20embolism%2C%20pump%20thrombosis%2C%20and%20major%20gastrointestinal%20bleeding%20and%20intracranial%20hemorrhage%20during%20therapy.%5CnRESULTS%3A%20We%20identified%20seven%20patients%3A%20five%20were%20male%2C%20the%20average%20body%20mass%20index%20was%2030%5Cu00a0kg%5C%2Fm2%2C%20and%20average%20age%20was%2056%5Cu00a0years.%20Preimplantation%20comorbidities%20included%20hypertension%20%28all%20patients%29%20and%20diabetes%20mellitus%2C%20ischemic%20cardiomyopathy%2C%20atrial%20fibrillation%2C%20and%20previous%20myocardial%20infarction%20%28four%5Cu00a0patients%20each%29.%20Overall%2C%20patients%20received%20warfarin%20for%203968%5Cu00a0days%20and%20apixaban%5C%2Frivaroxaban%20for%201459%5Cu00a0days.%20The%20warfarin%20group%20was%20within%20the%20therapeutic%20INR%20range%20%282.0-3.0%29%2030%25%20of%20the%20time.%20Complication%20rates%20did%20not%20differ%20between%20warfarin%20and%20apixaban%5C%2Frivaroxaban%3A%20strokes%2C%200.20%20vs%20none%2C%20non-CNS%20embolism%2C%200.54%20vs%20none%3B%20pump%20thrombosis%2C%200.27%20vs%20none%3B%20major%20gastrointestinal%20bleeding%2C%200.20%20vs%200.50%3B%20intracranial%20hemorrhage%2C%200.13%20vs%20none.%5CnCONCLUSIONS%3A%20Factor%20Xa%20inhibitors%20may%20be%20viable%20treatment%20options%20for%20CF-LVAD%20patients%20for%20whom%20warfarin%20therapy%20has%20failed.%20Large%20prospective%20studies%20are%20necessary%20to%20confirm%20these%20results.%22%2C%22date%22%3A%22Nov%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs11748-020-01371-w%22%2C%22ISSN%22%3A%221863-6713%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%22TIPQ3BD5%22%2C%22S7WF6DG3%22%2C%2264GCVCDC%22%2C%22WS63FIXU%22%2C%22QZHY2RIG%22%5D%2C%22dateModified%22%3A%222022-02-04T15%3A15%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22FNHSY2JN%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Letsou%20et%20al.%22%2C%22parsedDate%22%3A%222020-08-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLetsou%2C%20G.%20V.%2C%20Musfee%2C%20F.%20I.%2C%20Lee%2C%20A.%20D.%20et%20al.%20%282020%29.%20Ten-year%20survival%20with%20a%20continuous-flow%20left%20ventricular%20assist%20device%20and%20aortic%20valve%20closure.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B47%26lt%3B%5C%2Fi%26gt%3B%2C%20325%26%23x2013%3B328.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-19-7193%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-19-7193%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Ten-year%20survival%20with%20a%20continuous-flow%20left%20ventricular%20assist%20device%20and%20aortic%20valve%20closure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20V.%22%2C%22lastName%22%3A%22Letsou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fadi%20I.%22%2C%22lastName%22%3A%22Musfee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20D.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faisal%22%2C%22lastName%22%3A%22Cheema%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%20M.%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%5D%2C%22abstractNote%22%3A%22We%20report%20the%20long-term%20survival%20of%20a%2046-year-old%20man%20supported%20with%20a%20HeartMate%20II%20continuous-flow%20left%20ventricular%20assist%20device%20after%20complex%20repair%20of%20a%20bicuspid%20aortic%20valve%2C%20anomalous%20left%20main%20coronary%20artery%2C%20and%20dilated%20aorta.%20He%20has%20been%20maintained%20on%20an%20anticoagulation%20regimen%20of%20warfarin%20and%20low-dose%20aspirin%20without%20problems%20for%2010%20years%2C%20during%20which%20he%20has%20worked%20continuously%20and%20productively.%20Device%20flow%20has%20been%20kept%20at%2010%2C000%20rpm.%20Possible%20contributors%20to%20this%20long-term%20success%20include%20proper%20alignment%20of%20the%20device%20inflow%20cannula%2C%20pericardial%20patch%20closure%20of%20the%20left%20ventricular%20outflow%20tract%2C%20and%2C%20notably%2C%20the%20remarkable%20freedom%20from%20mechanical%20failure%20of%20the%20continuous-flow%20left%20ventricular%20assist%20device.%20Whether%20the%20higher%20flow%20rate%20produced%20by%20the%20pericardial%20patch%20closure%20contributes%20to%20pump%20longevity%20is%20unknown%20and%20merits%20further%20investigation.%22%2C%22date%22%3A%22Aug%201%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-19-7193%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%22TIPQ3BD5%22%2C%22YZAQAZIS%22%5D%2C%22dateModified%22%3A%222022-01-25T15%3A05%3A40Z%22%7D%7D%2C%7B%22key%22%3A%223IBSAC2U%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Maffei%20et%20al.%22%2C%22parsedDate%22%3A%222020-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMaffei%2C%20S.%20R.%2C%20Lamba%2C%20H.%20K.%2C%20Mensah%2C%20C.%20K.%20et%20al.%20%282020%29.%20Plasmapheresis%20in%20patients%20with%20heparin-induced%20thrombocytopenia%20requiring%20ventricular%20assist%20device.%20%26lt%3Bi%26gt%3BAnn%20Thorac%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B109%26lt%3B%5C%2Fi%26gt%3B%2C%20e439%26%23x2013%3Be440.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.athoracsur.2019.09.056%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.athoracsur.2019.09.056%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Plasmapheresis%20in%20patients%20with%20heparin-induced%20thrombocytopenia%20requiring%20ventricular%20assist%20device%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvador%20R.%22%2C%22lastName%22%3A%22Maffei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harveen%20K.%22%2C%22lastName%22%3A%22Lamba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cassius%20Kwasi%22%2C%22lastName%22%3A%22Mensah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arthur%22%2C%22lastName%22%3A%22Bracey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Civitello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Morgan%22%7D%5D%2C%22abstractNote%22%3A%22Anticoagulation%20with%20unfractionated%20heparin%20is%20vital%20to%20reduce%20the%20risk%20of%20thromboembolic%20events%20during%20cardiopulmonary%20bypass%20and%20left%20ventricular%20assist%20device%20placement.%20However%20patients%20with%20heparin-induced%20thrombocytopenia%20are%20at%20risk%20of%20developing%20immune-mediated%20thrombotic%20events.%20We%20describe%202%20patients%20with%20heparin-induced%20thrombocytopenia%20confirmed%20via%20serotonin%20release%20assay%20who%20were%20successfully%20treated%20with%20plasmapheresis%20exchange%20before%20left%20ventricular%20assist%20device%20placement.%22%2C%22date%22%3A%22Jun%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.athoracsur.2019.09.056%22%2C%22ISSN%22%3A%221552-6259%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%22KIXH6H5E%22%2C%229FBUJBMU%22%2C%22TIPQ3BD5%22%2C%22AAQ89W3S%22%2C%22S7WF6DG3%22%5D%2C%22dateModified%22%3A%222022-01-25T15%3A05%3A29Z%22%7D%7D%2C%7B%22key%22%3A%227G69KG9E%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Critsinelis%20et%20al.%22%2C%22parsedDate%22%3A%222020-05%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCritsinelis%2C%20A.%20C.%2C%20Lamba%2C%20H.%20K.%2C%20Nguyen%2C%20M.%20T.%20et%20al.%20%282020%29.%20Accuracy%20of%20postoperative%20risk%20scores%20for%20survival%20prediction%20in%20Interagency%20Registry%20for%20Mechanically%20Assisted%20Circulatory%20Support%20Profile%201%20continuous-flow%20left%20ventricular%20assist%20device%20recipients.%20%26lt%3Bi%26gt%3BASAIO%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B66%26lt%3B%5C%2Fi%26gt%3B%2C%20539%26%23x2013%3B546.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMAT.0000000000001044%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMAT.0000000000001044%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Accuracy%20of%20postoperative%20risk%20scores%20for%20survival%20prediction%20in%20Interagency%20Registry%20for%20Mechanically%20Assisted%20Circulatory%20Support%20Profile%201%20continuous-flow%20left%20ventricular%20assist%20device%20recipients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andre%20C.%22%2C%22lastName%22%3A%22Critsinelis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harveen%20K.%22%2C%22lastName%22%3A%22Lamba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michelle%20T.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%20R.%22%2C%22lastName%22%3A%22Conroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faisal%20H.%22%2C%22lastName%22%3A%22Cheema%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20B.%22%2C%22lastName%22%3A%22Civitello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%20M.%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%20P.%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Selby%20B.%22%2C%22lastName%22%3A%22Oberton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20K.%22%2C%22lastName%22%3A%22Rosengart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Morgan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhasis%22%2C%22lastName%22%3A%22Chatterjee%22%7D%5D%2C%22abstractNote%22%3A%22In%20this%20study%2C%20we%20sought%20to%20determine%20the%20accuracy%20of%20several%20critical%20care%20risk%20scores%20for%20predicting%20survival%20of%20Interagency%20Registry%20for%20Mechanically%20Assisted%20Circulatory%20Support%20%28INTERMACS%29%20Profile%201%20patients%20after%20continuous-flow%20left%20ventricular%20assist%20device%20%28CF-LVAD%29%20placement.%20We%20retrospectively%20analyzed%20the%20records%20of%20605%20patients%20who%20underwent%20CF-LVAD%20implantation%20between%202003%20and%202016.%20We%20calculated%20the%20preoperative%20HeartMate%20II%20Risk%20Score%20%28HMRS%29%20and%20preoperative%20Right%20Ventricular%20Failure%20Risk%20Score%20%28RVFRS%29%20and%20the%20following%20risk%20scores%20for%20postoperative%20days%201-5%3A%20HMRS%2C%20RVFRS%2C%20Model%20for%20End-stage%20Liver%20Disease%20%28MELD%29%2C%20MELD-eXcluding%20International%20Normalized%20Ratio%2C%20Post%20Cardiac%20Surgery%20%28POCAS%29%20risk%20score%2C%20Sequential%20Organ%20Failure%20Assessment%20%28SOFA%29%20risk%20score%2C%20and%20Acute%20Physiology%20and%20Chronic%20Health%20Evaluation%20III.%20The%20preoperative%20scores%20and%20the%20postoperative%20day%201%2C%205-day%20mean%2C%20and%205-day%20maximum%20scores%20were%20entered%20into%20a%20receiver%20operating%20characteristic%20curve%20analysis%20to%20examine%20accuracy%20for%20predicting%2030-day%2C%2090-day%2C%20and%201-year%20survival.%20The%20mean%20POCAS%20score%20was%20the%20best%20predictor%20of%2030-day%20and%2090-day%20survival%20%28area%20under%20the%20curve%20%5BAUC%5D%20%3D%200.869%20and%200.816%29.%20The%20postoperative%20mean%20RVFRS%20was%20the%20best%20predictor%20of%201-year%20survival%20%28AUC%20%3D%200.7908%29.%20The%20postoperative%20maximum%20and%20mean%20RVFRS%20and%20HMRS%20were%20more%20accurate%20than%20the%20preoperative%20scores.%20Both%20of%20these%20risk%20score%20measurements%20of%20acuity%20in%20the%20postoperative%20intensive%20care%20unit%20setting%20help%20predict%20early%20mortality%20after%20LVAD%20implantation.%22%2C%22date%22%3A%22May%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FMAT.0000000000001044%22%2C%22ISSN%22%3A%221538-943X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%229FBUJBMU%22%2C%22TIPQ3BD5%22%2C%22BCTBZ4XB%22%2C%22949A4W5I%22%2C%22VCK5HVUS%22%5D%2C%22dateModified%22%3A%222022-01-25T15%3A04%3A18Z%22%7D%7D%2C%7B%22key%22%3A%224JTPRX5F%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chou%20et%20al.%22%2C%22parsedDate%22%3A%222020-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChou%2C%20B.%20P.%2C%20Lamba%2C%20H.%20K.%2C%20Cheema%2C%20F.%20H.%20et%20al.%20%282020%29.%20Outcomes%20of%20repeat%20left%20ventricular%20assist%20device%20exchange.%20%26lt%3Bi%26gt%3BASAIO%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B66%26lt%3B%5C%2Fi%26gt%3B%2C%2064%26%23x2013%3B68.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMAT.0000000000000928%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMAT.0000000000000928%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Outcomes%20of%20repeat%20left%20ventricular%20assist%20device%20exchange%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brendan%20P.%22%2C%22lastName%22%3A%22Chou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harveen%20K.%22%2C%22lastName%22%3A%22Lamba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faisal%20H.%22%2C%22lastName%22%3A%22Cheema%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20B.%22%2C%22lastName%22%3A%22Civitello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%20M.%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%20P.%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Selby%22%2C%22lastName%22%3A%22Oberton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ziad%20A.%22%2C%22lastName%22%3A%22Taimeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20K.%22%2C%22lastName%22%3A%22Rosengart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Morgan%22%7D%5D%2C%22abstractNote%22%3A%22Implantable%20continuous-flow%20left%20ventricular%20assist%20devices%20%28CF-LVADs%29%20are%20used%20for%20long-term%20LV%20support%20in%20bridging%20patients%20to%20heart%20transplantation%20or%20as%20destination%20therapy.%20With%20prolonged%20support%20times%2C%20some%20patients%20will%20have%20repeat%20complications%20necessitating%20multiple%20device%20exchanges.%20To%20elucidate%20the%20safety%20and%20efficacy%20of%20repeat%20device%20exchange%2C%20we%20retrospectively%20reviewed%20data%20from%2025%20patients%20who%20underwent%20two%20or%20more%20CF-LVAD%20implantations%20between%20July%202005%20and%20August%202017.%20Indications%20for%20exchange%20were%20thrombus%5C%2Fhemolysis%20%28n%20%3D%208%2C%2032%25%29%2C%20electromechanical%20device%20malfunction%20%28n%20%3D%2014%2C%2056%25%29%2C%20and%20infection%20%28n%20%3D%203%2C%2012%25%29.%20The%20implanted%20devices%20were%20the%20HeartMate%20II%20%28n%20%3D%2013%2C%2052%25%29%2C%20the%20HeartWare%20HVAD%20%28n%20%3D%2011%2C%2044%25%29%2C%20and%20the%20Jarvik%202000%20%28n%20%3D%201%2C%204%25%29.%20Average%20hospital%20length%20of%20stay%20was%2044%20days%20%28range%204-221%20days%29%2C%20and%2017%20patients%20%2868%25%29%20survived%20to%20discharge.%20Average%20duration%20of%20support%20after%20the%20most%20recent%20LVAD%20implantation%20was%20802%20days%20%28range%201-3%2C229%20days%29.%20Overall%20survival%20was%2072%25%20at%201%20year%20and%2060%25%20at%202%20years.%20Postoperative%20complications%20included%20respiratory%20failure%20in%20five%20patients%20%2820%25%29%2C%20device%20infection%20in%20five%20%2820%25%29%2C%20bleeding%20requiring%20reoperation%20in%20four%20%2816%25%29%2C%20neurologic%20dysfunction%20in%20four%20%2816%25%29%2C%20and%20acute%20renal%20failure%20in%20two%20%288%25%29.%20Overall%2C%20our%20data%20suggest%20that%20repeat%20LVAD%20exchange%20is%20a%20feasible%20option%20for%20patients%20with%20recurrent%20device-related%20complications.%22%2C%22date%22%3A%22Jan%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FMAT.0000000000000928%22%2C%22ISSN%22%3A%221538-943X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%229FBUJBMU%22%2C%22TIPQ3BD5%22%2C%22BCTBZ4XB%22%2C%22AAQ89W3S%22%2C%22S7WF6DG3%22%2C%22949A4W5I%22%2C%2222K3TRJD%22%5D%2C%22dateModified%22%3A%222022-01-25T15%3A05%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22KG3ILPM3%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hinds%20et%20al.%22%2C%22parsedDate%22%3A%222019-12%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHinds%2C%20E.%20D.%2C%20Marin%2C%20M.%20J.%2C%20George%2C%20J.%20et%20al.%20%282019%29.%20A%20coronary%20cameral%20fistula%20treated%20with%20coil%20embolization.%20%26lt%3Bi%26gt%3BJRSM%20Cardiovasc%20Dis%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B8%26lt%3B%5C%2Fi%26gt%3B%2C%202048004019856801.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F2048004019856801%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F2048004019856801%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20coronary%20cameral%20fistula%20treated%20with%20coil%20embolization%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethan%20D.%22%2C%22lastName%22%3A%22Hinds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manuel%20J.%22%2C%22lastName%22%3A%22Marin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%22%2C%22lastName%22%3A%22Delgado%22%7D%5D%2C%22abstractNote%22%3A%22A%2056-year-old%20man%20who%20had%20twice%20previously%20undergone%20orthotopic%20heart%20transplantation%20was%20admitted%20with%20dyspnea%20and%20heart%20failure%20symptoms.%20A%20biopsy%20excluded%20rejection.%20Left%20heart%20catheterization%20revealed%20a%20coronary%20cameral%20fistula.%20After%20the%20patient%20was%20given%20mild%20diuretics%2C%20his%20condition%20improved.%20No%20significant%20fistula%20flow%20was%20detected%2C%20and%20he%20was%20discharged.%20Several%20months%20later%2C%20the%20patient%20was%20readmitted%20with%20worsening%20chest%20pain%20and%20dyspnea.%20Left%20ventricular%20end-diastolic%20pressure%20and%20flow%20through%20the%20fistula%20were%20increased.%20To%20correct%20the%20coronary%20cameral%20fistula%2C%20we%20performed%20a%20coil%20embolization%20without%20complications.%20Several%20months%20later%20at%20follow-up%2C%20the%20patient%26%23039%3Bs%20symptoms%20had%20resolved%2C%20and%20his%20left%20ventricular%20end-diastolic%20pressure%20had%20normalized.%20We%20conclude%20that%20coronary%20fistulas%20may%20be%20caused%20by%20trauma%20to%20the%20heart%20during%20the%20de-airing%20process%2C%20which%20may%20be%20prevented%20in%20the%20future%20with%20the%20development%20of%20safer%20and%20more%20effective%20de-airing%20techniques.%22%2C%22date%22%3A%222019%20Jan-Dec%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1177%5C%2F2048004019856801%22%2C%22ISSN%22%3A%222048-0040%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22TIPQ3BD5%22%2C%22WS63FIXU%22%5D%2C%22dateModified%22%3A%222022-02-04T15%3A14%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22HQI7PV4E%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Anjum%20et%20al.%22%2C%22parsedDate%22%3A%222018-09%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAnjum%2C%20A.%2C%20Kurihara%2C%20C.%2C%20Critsinelis%2C%20A.%20et%20al.%20%282018%29.%20Acute%20kidney%20injury%20after%20implantation%20of%20a%20left%20ventricular%20assist%20device%3A%20a%20comparison%20of%20axial-flow%20%28HeartMate%20II%29%20and%20centrifugal-flow%20%28HeartWare%20HVAD%29%20devices.%20%26lt%3Bi%26gt%3BJ%20Artif%20Organs%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B21%26lt%3B%5C%2Fi%26gt%3B%2C%20285%26%23x2013%3B292.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10047-018-1047-0%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10047-018-1047-0%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20kidney%20injury%20after%20implantation%20of%20a%20left%20ventricular%20assist%20device%3A%20a%20comparison%20of%20axial-flow%20%28HeartMate%20II%29%20and%20centrifugal-flow%20%28HeartWare%20HVAD%29%20devices%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azeen%22%2C%22lastName%22%3A%22Anjum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chitaru%22%2C%22lastName%22%3A%22Kurihara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andre%22%2C%22lastName%22%3A%22Critsinelis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masashi%22%2C%22lastName%22%3A%22Kawabori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tadahisa%22%2C%22lastName%22%3A%22Sugiura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20B.%22%2C%22lastName%22%3A%22Civitello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Whitson%20B.%22%2C%22lastName%22%3A%22Etheridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%20M.%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%20K.%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%20P.%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Morgan%22%7D%5D%2C%22abstractNote%22%3A%22Continuous-flow%20left%20ventricular%20assist%20devices%20%28CF-LVADs%29%20are%20increasingly%20being%20used%20to%20treat%20advanced%2C%20refractory%20chronic%20heart%20failure.%20Herein%2C%20we%20sought%20to%20determine%20the%20incidence%20of%20postoperative%20acute%20kidney%20injury%20%28AKI%29%20in%20axial-flow%20%28HeartMate%20II%3B%20HM-II%29%20and%20centrifugal-flow%20%28HVAD%29%20CF-LVAD%20recipients%2C%20as%20well%20as%20the%20effect%20of%20AKI%20on%20mortality.%20The%20study%20cohort%20comprised%20520%20patients%20who%20received%20a%20HM-II%20%28n%5Cu2009%3D%5Cu2009398%29%20or%20HVAD%20%28n%5Cu2009%3D%5Cu2009122%29%20at%20our%20center%20between%20November%202003%20and%20March%202016.%20Their%20records%20were%20reviewed%20to%20determine%20the%20incidence%20of%20RIFLE-defined%20AKI%20after%20LVAD%20implantation.%20We%20compared%20the%20perioperative%20characteristics%2C%20postoperative%20complications%2C%20and%20survival%20rates%20of%20the%20patients%20with%20and%20without%20AKI%20and%20differentiated%20the%20outcomes%20based%20on%20device%20type%20%28HM-II%20or%20HVAD%29.%20Seventy-five%20patients%20%2814.4%25%29%20developed%20AKI%20postoperatively.%20Patients%20with%20AKI%20after%20LVAD%20implantation%20had%20significantly%20reduced%20survival%20compared%20to%20patients%20without%20AKI%20%28p%5Cu2009%3D%5Cu20090.01%29.%20Cox%20proportional%20hazards%20models%20showed%20that%20AKI%20was%20a%20significant%20independent%20predictor%20of%20mortality%20%28HR%5Cu2009%3D%5Cu20091.54%2C%20p%5Cu2009%3D%5Cu20090.03%29.%20Preoperative%20mechanical%20circulatory%20support%20and%20prolonged%20cardiopulmonary%20bypass%20time%20were%20independent%20predictors%20of%20AKI.%20The%20incidence%20of%20AKI%20was%20similar%20for%20HM-II%20and%20HVAD%20recipients%20%28p%5Cu2009%3D%5Cu20090.25%29.%20There%20was%20no%20significant%20difference%20in%20AKI%20rates%20for%20the%20HM-II%20and%20HVAD%20recipients.%20Developing%20AKI%20adversely%20affected%20survival.%22%2C%22date%22%3A%22Sep%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10047-018-1047-0%22%2C%22ISSN%22%3A%221619-0904%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%229FBUJBMU%22%2C%22TIPQ3BD5%22%2C%22YQCNXVUF%22%2C%22AAQ89W3S%22%2C%22WS63FIXU%22%5D%2C%22dateModified%22%3A%222022-02-04T15%3A14%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22QZ7NF7GX%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gohar%20et%20al.%22%2C%22parsedDate%22%3A%222017%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGohar%2C%20S.%2C%20Sheth%2C%20S.%20and%20%26lt%3Bstrong%26gt%3BDelgado%26lt%3B%5C%2Fstrong%26gt%3B%2C%20R.%2C%20III%20%282017%29.%20Optimization%20of%20right%20ventricular%20function%20preoperatively%20for%20LVAD%20implantation.%20In%20%26lt%3Bi%26gt%3BMechanical%20Circulatory%20Support%20for%20Advanced%20Heart%20Failure%3A%20A%20Texas%20Heart%20Institute%5C%2FBaylor%20College%20of%20Medicine%20Approach%26lt%3B%5C%2Fi%26gt%3B%20%2835%26%23x2013%3B55%29.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2F978-3-319-65364-8_3.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Optimization%20of%20right%20ventricular%20function%20preoperatively%20for%20LVAD%20implantation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Gohar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Sheth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%2C%20III%22%2C%22lastName%22%3A%22Delgado%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22bookTitle%22%3A%22Mechanical%20Circulatory%20Support%20for%20Advanced%20Heart%20Failure%3A%20A%20Texas%20Heart%20Institute%5C%2FBaylor%20College%20of%20Medicine%20Approach%22%2C%22date%22%3A%222017%22%2C%22language%22%3A%22%22%2C%22ISBN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22TIPQ3BD5%22%5D%2C%22dateModified%22%3A%222019-01-03T15%3A36%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22G8FJJEMX%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jabbar%20et%20al.%22%2C%22parsedDate%22%3A%222015-02%22%2C%22numChildren%22%3A7%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BJabbar%2C%20A.%20A.%2C%20Franklin%2C%20W.%20J.%2C%20Simpson%2C%20L.%20et%20al.%20%282015%29.%20Improved%20systemic%20saturation%20after%20ventricular%20assist%20device%20implantation%20in%20a%20patient%20with%20decompensated%20dextro-transposition%20of%20the%20great%20arteries%20after%20the%20Fontan%20procedure.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B42%26lt%3B%5C%2Fi%26gt%3B%2C%2040%26%23x2013%3B43.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-13-3374%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-13-3374%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Improved%20systemic%20saturation%20after%20ventricular%20assist%20device%20implantation%20in%20a%20patient%20with%20decompensated%20dextro-transposition%20of%20the%20great%20arteries%20after%20the%20Fontan%20procedure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%20Abdul%22%2C%22lastName%22%3A%22Jabbar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wayne%20J.%22%2C%22lastName%22%3A%22Franklin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20B.%22%2C%22lastName%22%3A%22Civitello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%20M.%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%5D%2C%22abstractNote%22%3A%22We%20report%20the%20successful%20implantation%20of%20a%20HeartMate%20II%20left%20ventricular%20assist%20device%20after%20a%20failed%20Fontan%20procedure%20in%20a%20patient%20with%20dextro-transposition%20of%20the%20great%20arteries.%20The%20patient%20had%20developed%20significant%20intrapulmonary%20arteriovenous%20shunting.%20Despite%20the%20theoretical%20risk%20of%20worsening%20intrapulmonary%20shunting%20due%20to%20the%20decrease%20in%20systemic%20vascular%20resistance%20after%20device%20implantation%2C%20our%20patient%20did%20well.%20He%20was%20discharged%20from%20the%20hospital%20in%20stable%20condition%20and%20had%20better%20oxygen%20saturation%20than%20before%20the%20device%20was%20implanted.%20To%20our%20knowledge%2C%20ours%20is%20the%202nd%20report%20of%20the%20use%20of%20a%20ventricular%20assist%20device%20after%20the%20failure%20of%20a%20Fontan%20procedure%2C%20and%20the%20first%20report%20concerning%20the%20effect%20of%20ventricular%20assist%20device%20implantation%20on%20intrapulmonary%20shunting.%22%2C%22date%22%3A%22Feb%202015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-13-3374%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%229FBUJBMU%22%2C%22TIPQ3BD5%22%2C%22GW95W9I8%22%2C%22AAQ89W3S%22%5D%2C%22dateModified%22%3A%222022-01-25T15%3A05%3A19Z%22%7D%7D%5D%7D
Chou, BP, Critsinelis, A., Lamba, HK et al. (2021). Soporte con dispositivo de asistencia ventricular izquierda de flujo continuo en pacientes con miocardiopatía isquémica versus no isquémica. Tex Corazón Inst J 48, E207241. https://doi.org/10.14503/THIJ-20-7241.
Parikh, VY, Parikh, UM, Moctezuma-Ramírez, A. et al. (2020). Inhibidores del factor Xa en pacientes con dispositivos de asistencia ventricular izquierda de flujo continuo. Cirugía cardiovascular torácica gen 68, 1278-1284. https://doi.org/10.1007/s11748-020-01371-w.
Letsou, GV, Musfee, FI, Lee, AD et al. (2020). Supervivencia a diez años con un dispositivo de asistencia ventricular izquierda de flujo continuo y cierre de la válvula aórtica. Tex Corazón Inst J 47, 325-328. https://doi.org/10.14503/THIJ-19-7193.
Maffei, SR, Lamba, HK, Mensah, CK et al. (2020). Plasmaféresis en pacientes con trombocitopenia inducida por heparina que requieren dispositivo de asistencia ventricular. Ann Thorac Cirugía 109, e439-e440. https://doi.org/10.1016/j.athoracsur.2019.09.056.
Critsinelis, AC, Lamba, HK, Nguyen, MT et al. (2020). Precisión de las puntuaciones de riesgo posoperatorio para la predicción de supervivencia en el Registro interinstitucional para receptores de dispositivos de asistencia ventricular izquierda de flujo continuo Perfil 1 de soporte circulatorio asistido mecánicamente. ASAIO J. 66, 539-546. https://doi.org/10.1097/MAT.0000000000001044.
Chou, BP, Lamba, HK, Cheema, FH et al. (2020). Resultados del intercambio repetido del dispositivo de asistencia ventricular izquierda. ASAIO J. 66, 64-68. https://doi.org/10.1097/MAT.0000000000000928.
Hinds, ED, Marin, MJ, George, J. et al. (2019). Una fístula cameral coronaria tratada con embolización con espiral. Enfermedad cardiovascular JRSM 8, 2048004019856801. https://doi.org/10.1177/2048004019856801.
Anjum, A., Kurihara, C., Critsinelis, A. et al. (2018). Lesión renal aguda después de la implantación de un dispositivo de asistencia ventricular izquierda: una comparación de dispositivos de flujo axial (HeartMate II) y de flujo centrífugo (HeartWare HVAD). Órganos J Artif 21, 285-292. https://doi.org/10.1007/s10047-018-1047-0.
Gohar, S., Sheth, S. y Delgado, R., III (2017). Optimización de la función ventricular derecha preoperatoriamente para la implantación de DAVI. En Soporte circulatorio mecánico para la insuficiencia cardíaca avanzada: un enfoque del Texas Heart Institute/Baylor College of Medicine (35–55). https://doi.org/10.1007/978-3-319-65364-8_3.
Jabbar, AA, Franklin, WJ, Simpson, L. et al. (2015). Mejora de la saturación sistémica tras el implante de un dispositivo de asistencia ventricular en un paciente con dextrotransposición descompensada de las grandes arterias tras el procedimiento de Fontan. Tex Corazón Inst J 42, 40-43. https://doi.org/10.14503/THIJ-13-3374.
Fragmentos de código PHP Desarrollado por: XYZScripts.com